Drug intelligence / Profile preview

yiqi xiaozheng decoction

Development stage: Unknown
Lead developer: Xiyuan Hospital
Administration: Oral

Overview

Yiqi Xiaozheng Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences for the treatment of moderate to severe intrauterine adhesions (IUA). Based on the clinical experience of Cai Lianxiang, the decoction is used in a phased integrated approach alongside Western medical management (such as hysteroscopic adhesiolysis). It specifically targets the TCM pattern of kidney deficiency and blood stasis, aiming to reduce adhesion severity, improve menstruation, and enhance endometrial receptivity. The formula is typically administered orally as part of a sequential regimen with other TCM decoctions like Yishen Zengmo Decoction.

Other names: Yiqi Xiaozheng Decoction

Beyond the preview

Go deeper on yiqi xiaozheng decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on yiqi xiaozheng decoction.

Explore the full profile